Fears of MERS Virus Prompt Broadening of Cautions in South Korea

Officials nearly doubled the number of quarantined people, temporarily closed over 700 kindergartens and schools, and refused to identify the hospitals where infections had been confirmed.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Viruses South Korea Saudi Arabia SARS (Severe Acute Respiratory Syndrome) Qatar China Bahrain Hospitals Hong Kong MERS (Middle East Respiratory Syndrome) World Health Organization Source Type: news

Related Links:

tinez “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)”, the novel coronavirus, is responsible for the ongoing worldwide pandemic. “World Health Organization (WHO)” assigned an “International Classification of Diseases (ICD)” code—“COVID-19”-as the name of the new disease. Coronaviruses are generally transferred by people and many diverse species of animals, including birds and mammals such as cattle, camels, cats, and bats. Infrequently, the coronavirus can be transferred from animals to humans, and then propagate am...
Source: Sensors - Category: Biotechnology Authors: Tags: Article Source Type: research
We don't have vaccines for SARS, MERS, or HIV. Does that spell doom for efforts to develop a vaccine for SARS-CoV-2?Medscape Internal Medicine
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Internal Medicine Commentary Source Type: news
COVID-19 is caused by the Severe Acute Respiratory Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus with a positive-polarity, single-stranded RNA genome. The initial outbreak of the pandemic began in December 2019, and it is affecting the human health of the global community. In common with previous pandemics (Influenza H1N1 and SARS-CoV) and the epidemics of Middle east respiratory syndrome (MERS)-CoV, CoVs target bronchial and alveolar epithelial cells. Virus protein ligands (e.g., haemagglutinin or trimeric spike glycoprotein for Influenza and CoV, respectively) interact with cellular receptors, such as (dependin...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Coronaviruses are pathogens that target the human respiratory system. Previous outbreaks of coronaviruses include severe acute respiratory syndrome (SARS) [1] and Middle East respiratory syndrome (MERS) [2]. In December, 2019, an outbreak of pneumonia of unknown cause was reported in Wuhan, China [3]. Chinese scientists rapidly identified the causative agent as a novel coronavirus (SARS-CoV-2) by sequencing the complete genome from lower respiratory tract samples of patients in Wuhan [4]. The WHO named this disease “coronavirus disease 2019” (COVID-19).
Source: Radiotherapy and Oncology - Category: Radiology Authors: Tags: COVID-19 Rapid Letter Source Type: research
The current pandemic coronavirus, severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), was recently identified in patients with an acute respiratory syndrome, coronavirus disease 2019 (COVID-19). To compare its pathogenesis with that of previously emerging coronaviruses, we inoculated cynomolgus macaques with SARS-CoV-2 or Middle East respiratory syndrome (MERS)–CoV and compared the pathology and virology with historical reports of SARS-CoV infections. In SARS-CoV-2–infected macaques, virus was excreted from nose and throat in the absence of clinical signs and detected in type I and II pneumocyte...
Source: ScienceNOW - Category: Science Authors: Tags: Medicine, Diseases, Microbiology reports Source Type: news
CONCLUSION: Lung function abnormalities, psychological impairment and reduced exercise capacity were common in SARS and MERS survivors. Clinicians should anticipate and investigate similar long-term outcomes in COVID-19 survivors. PMID: 32449782 [PubMed - as supplied by publisher]
Source: Journal of Rehabilitation Medicine - Category: Rehabilitation Tags: J Rehabil Med Source Type: research
Publication date: June 2020Source: Journal of Hospital Infection, Volume 105, Issue 2Author(s): J.A. Al-Tawfiq, A.J. Rodriguez-Morales
Source: Journal of Hospital Infection - Category: Infectious Diseases Source Type: research
Publication date: June 2020Source: Journal of Hospital Infection, Volume 105, Issue 2Author(s): J.A. Al-Tawfiq, Z.A. Memish
Source: Journal of Hospital Infection - Category: Infectious Diseases Source Type: research
ty on Thrombosis, Haemostasis+ Abstract The novel coronavirus disease of 2019 (COVID-19) pandemic, as declared by the World Health Organization, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Cardiovascular disease and, in particular, venous thromboembolism (VTE) has emerged as an important consideration in the management of hospitalized patients with COVID-19. The diagnosis of VTE using standardized objective testing is problematic in these patients, given the risk of infecting non-COVID-19 hospitalized patients and hospital personnel, coupled with the usual challenges of performing...
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Tags: J Thromb Haemost Source Type: research
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics or vaccines to this ongoing global threat, type I and type III interferons (IFNs) are currently being evaluated for their efficacy. Both the role of IFNs and the use of recombinant IFNs in two related, highly pathogenic coronaviruses, SARS-CoV and MERS-CoV, have been controversial in terms of their protective effects in the host. In this review, we describe the recent progress in our understanding of both type I and type III IFN-mediated i...
Source: Cell Host and Microbe - Category: Microbiology Authors: Tags: Cell Host Microbe Source Type: research
More News: Bahrain Health | Health | Hospitals | International Medicine & Public Health | MERS | Middle East Health | Qatar Health | Respiratory Medicine | SARS | Schools | South Korea Health | WHO